Milestone Fees. Licensee will pay Milestone Fees indicated in Section 3.1(b) of the Patent & Technology License Agreement by the Quarterly Payment Deadline for the Contract Quarter in which the milestone events set forth in Section 3.1(b) of the Patent & Technology License Agreement are achieved.
Appears in 17 contracts
Sources: Patent & Technology License Agreement (American Boarding Co), Patent & Technology License Agreement (American Boarding Co), Patent & Technology License Agreement (American Boarding Co)
Milestone Fees. Licensee will pay Milestone Fees indicated in Section 3.1(b) of the Patent & Technology License Agreement by the Quarterly Payment Deadline for the Contract Quarter in which the milestone events set forth in Section 3.1(b) of the Patent & Technology License Agreement are achieved.
Appears in 10 contracts
Sources: Patent License Agreement, Patent License Agreement (Aileron Therapeutics Inc), Patent License Agreement (Energy Exploration Technologies, Inc.)
Milestone Fees. Licensee will pay Milestone Fees indicated in Section 3.1(b) of the Patent & Technology License Agreement by the Quarterly Payment Deadline for the Contract Quarter in which the milestone events set forth in Section 3.1(b) of the Patent & Technology License Agreement are achieved. Notwithstanding anything to the contrary, each Milestone Fee is payable only once under this Agreement, with respect to the initial accomplishment thereof, regardless of the number of Licensed Products (or indications therefor) or the number of times such milestone may be achieved.
Appears in 3 contracts
Sources: Patent License Agreement (Ikena Oncology, Inc.), Patent License Agreement (Aeglea BioTherapeutics, Inc.), Patent License Agreement (Aeglea BioTherapeutics, Inc.)
Milestone Fees. Licensee will pay Milestone Fees indicated in Section 3.1(b) and 20.2 of the Patent & Technology License Agreement by the Quarterly Payment Deadline for the Contract Quarter in which the milestone events set forth in Section 3.1(b) and 20.2 of the Patent & Technology License Agreement are achieved.
Appears in 2 contracts
Sources: Patent License Agreement (TFF Pharmaceuticals, Inc.), Patent License Agreement (TFF Pharmaceuticals, Inc.)
Milestone Fees. Licensee will pay the Milestone Fees indicated in Section 3.1(b3.1(a) of the Patent & Technology License Agreement by the Quarterly Payment Deadline for the Contract Quarter in which the milestone events set forth in Section 3.1(b3.1(a) of the Patent & Technology License Agreement are achieved.
Appears in 1 contract
Sources: Patent License Agreement (TFF Pharmaceuticals, Inc.)
Milestone Fees. Licensee will pay Milestone Fees indicated in Section 3.1(b) of the Patent & Technology License Agreement by the Quarterly Payment Deadline for the Contract Quarter in which the milestone events set forth in Section 3.1(b) of the Patent & Technology License Agreement are achieved, with the exception of the Milestone Fee for Milestone 2 that will be paid by [**].
5. Milestone Event 3 as set forth in Section 3.1(b)
Appears in 1 contract
Sources: Patent License Agreement (Aileron Therapeutics Inc)
Milestone Fees. Licensee will pay Milestone Fees indicated in Section 3.1(b) of the Patent & Technology License Agreement by the Quarterly Payment Deadline of the first to occur of (i) the achievement of the applicable milestone, or (ii) the deadline for the Contract Quarter in which the such milestone events set forth in Section 3.1(b) of the Patent & Technology License Agreement are achievedAgreement, as applicable.
Appears in 1 contract
Milestone Fees. Licensee will pay Milestone Fees indicated in Section 3.1(b) of the Patent & Technology License Agreement by the Quarterly Payment Deadline for the Contract Quarter in which the milestone events set forth in Section 3.1(b) of the Patent & Technology License Agreement are achieved.. and elsewhere in the Patent License Agreement is hereby deleted and replaced with
Appears in 1 contract
Sources: Patent License Agreement (Aileron Therapeutics Inc)